MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer-Reference-Cited by-同舟云学术

MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer

Published:2015-11-05 Issue:41 Volume:6 Page:43869-43880
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Gemoll Timo¹,Strohkamp Sarah¹,Schillo Katharina¹,Thorns Christoph²,Habermann Jens K.¹

Affiliation:

1. Section for Translational Surgical Oncology and Biobanking, Department of Surgery, University of Lübeck and University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany

2. Department of Pathology, University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Peptidomes Extracted from Healthy Tissue and Tumor Tissue of the Parotid Glands and Saliva Samples;International Journal of Molecular Sciences;2024-08-13

2. Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.;Clinical and Experimental Medicine;2024-03-16

3. Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases;2024-01-25

4. Prospective on Imaging Mass Spectrometry in Clinical Diagnostics;Molecular & Cellular Proteomics;2023-09

5. Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming;Cellular Oncology;2022-09-28